Abrdn PLC Zai Lab LTD Transaction History

Abrdn PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 20, 2024	BUY	$30.21 - $48.1 $89,633 - $142,712	2,967 Added 10.38%	31,547 $1.05 Million
Q1 2023 Apr 28, 2023	BUY	$30.21 - $48.1 $89,633 - $142,712	2,967 Added 10.38%	31,547 $1.05 Million
Q4 2022 Jun 20, 2024	BUY	$22.28 - $38.71 $636,762 - $1.11 Million	28,580 New	28,580 $877,000
Q4 2022 Feb 09, 2023	BUY	$22.28 - $38.71 $137,333 - $238,608	6,164 Added 27.5%	28,580 $877,000
Q3 2022 Nov 10, 2022	BUY	$34.2 - $51.69 $124,864 - $188,720	3,651 Added 19.46%	22,416 $767,000
Q2 2022 Aug 05, 2022	BUY	$23.14 - $49.68 $241,535 - $518,559	10,438 Added 125.35%	18,765 $651,000
Q1 2022 May 04, 2022	BUY	$27.77 - $64.4 $6,831 - $15,842	246 Added 3.04%	8,327 $366,000
Q4 2021 Feb 08, 2022	BUY	$54.9 - $105.21 $31,512 - $60,390	574 Added 7.65%	8,081 $509,000
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $33,180 - $56,364	316 Added 4.39%	7,507 $791,000
Q2 2021 Aug 10, 2021	BUY	$125.11 - $180.0 $142,375 - $204,840	1,138 Added 18.8%	7,191 $1.27 Million
Q1 2021 May 06, 2021	BUY	$126.27 - $191.71 $138,013 - $209,539	1,093 Added 22.04%	6,053 $808,000
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $176,252 - $291,116	2,151 Added 76.58%	4,960 $671,000
Q3 2020 Oct 21, 2020	BUY	$73.3 - $89.48 $205,899 - $251,349	2,809 New	2,809 $234,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.